lvrachЛечащий ВрачLechaschi Vrach1560-51752687-118110.26295/OS.2020.57.17.004lvrach-215Research ArticleСтатьиДиетотерапия в лечении псориаза и коморбидного метаболического синдромаNutritional interventions in treatment of psoriasis and metabolic syndromeУфимцеваМ. А.UfimtsevaM. A.

Ekaterinburg

mail-m@mail.ruПоповА. А.PopovA. A.

Ekaterinburg

noemail@neicon.ruФедотоваЛ. В.FedotovaL. V.

Ekaterinburg

noemail@neicon.ruМыльниковаЕ. С.MylnikovaE. S.

Ekaterinburg

noemail@neicon.ruБочкаревЮ. М.BochkarevYu. M.

Ekaterinburg

noemail@neicon.ruЖунисоваД. С.ZhunisovaD. S.

Ekaterinburg

noemail@neicon.ruФГБОУ ВО Уральский ГМУ Минздрава РоссииРоссияFederal State Budgetary Institution of Higher Professional Education Urals State Medical University of the Ministry of Healthcare of the Russian FederationRussian Federation2020230620210111922Copyright © Уфимцева М.А., Попов А.А., Федотова Л.В., Мыльникова Е.С., Бочкарев Ю.М., Жунисова Д.С., 20212021Уфимцева М.А., Попов А.А., Федотова Л.В., Мыльникова Е.С., Бочкарев Ю.М., Жунисова Д.С.Ufimtseva M.A., Popov A.A., Fedotova L.V., Mylnikova E.S., Bochkarev Y.M., Zhunisova D.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.lvrach.ru/jour/article/view/215

Псориаз распространенный хронический дерматоз, который нередко ассоциирован с метаболическим синдромом и его компонентами. Метаболический синдром способствует более тяжелому течению псориаза. Ожирение является заболеванием с мультифакториальным генезом, на развитие которого во многом влияют генетические факторы. У носителей гена FTO отмечаются более тяжелое течение псориаза, повышенный риск развития ожирения, псориатического артрита и метаболических нарушений. Диетотерапия является одним из важных методов лечения псориаза и коморбидного метаболического синдрома. В обзоре представлены современные данные об особенностях пищевых привычек пациентов с псориазом, влиянии снижения массы тела и использования пищевых добавок на течение хронического дерматоза.

Psoriasis is a common chronic dermatosis associated with metabolic syndrome and its components. Metabolic syndrome contributes to severe psoriasis. Obesity is a multifactorial disease and its development is influenced by genetic factors. Carriers of the FTO gene risk allele are associated with more severe psoriasis, higher risk of obesity, psoriatic arthritis and metabolic disorders. Nutritional intervention plays an important role in psoriasis and co-morbid metabolic syndrome management. The article reviews current data regarding dietary habits of psoriasis patients, impact of weight reduction and dietary supplements administration on psoriasis. 

FTOPremiumВитамин DДерматовенерологияДиетаЛечениеМетаболический синдромНутрициологияОжирениеОмега-3 полиненасыщенные жирные кислотыПолиморфизм геновПсориазТерапияЭффективностьpsoriasismetabolic syndromeobesitygene polymorphismalpha-ketoglutarate-dependent dioxygenase FTOdietvitamin Domega-3 fatty acidstreatmenteffectivenessReferencesRodríguez-Zúñiga M. J. M., García-Perdomo H. A. Systematic Review and MetaAnalysis of the Association Between Psoriasis and Metabolic Syndrome // J Am Acad Dermatol. 2017; 77 (4): 657-666. DOI: 10.1016/j.jaad.2017.04.1133.Rodríguez-Zúñiga M. J. M., García-Perdomo H. A. Systematic Review and MetaAnalysis of the Association Between Psoriasis and Metabolic Syndrome // J Am Acad Dermatol. 2017; 77 (4): 657-666. DOI: 10.1016/j.jaad.2017.04.1133.Schwarz P. E. H., Pinter A., Melzer N., Barteczek P. Reinhardt M. ERAPSO: Revealing the High Burden of Obesity in German Psoriasis Patients // Dermatol Ther (Heidelb). 2019; 9 (3): 579-587. DOI: 10.1007/s13555-019-0314-1.Schwarz P. E. H., Pinter A., Melzer N., Barteczek P. Reinhardt M. ERAPSO: Revealing the High Burden of Obesity in German Psoriasis Patients // Dermatol Ther (Heidelb). 2019; 9 (3): 579-587. DOI: 10.1007/s13555-019-0314-1.Хисматуллина З. Р., Аминева А. М., Курочкин Д. П., Гареева Д. Ф., Загидуллин Н. Ш. Псориаз, псориатический артрит, метаболические нарушения и сердечно-сосудистые заболевания. Что общего? // Клиническая дерматология и венерология. 2020; 19 (2): 139-147. DOI: 10.17116/klinderma202019021139.Khismatullina Z. R., Amineva A. M., Kurochkin D. P., Gareeva D. F., Zagidullin N. Sh. [Psoriaz, psoriaticheskii artrit, metabolicheskie narusheniya I serdechno-sosudistye zabolevaniya. Chto obschego?] Psoriasis, psoriatic arthritis, metabolic disorders and cardiovas-cular disease. What is common?] // Klinicheskaya dermatologiya i venerologiya. 2020; 19 (2): 139-147. (In Russ.). DOI: 10.17116/klinderma202019021139.Timóteo A. T. Diet in Patients with Metabolic Syndrome: What Is the Ideal Macronutrient Composition? // Rev Port Cardiol. 2018; 37 (12): 1001-1006. DOI: 10.1016/j.repc.2017.11.013.Timóteo A. T. Diet in Patients with Metabolic Syndrome: What Is the Ideal Macronutrient Composition? // Rev Port Cardiol. 2018; 37 (12): 1001-1006. DOI: 10.1016/j.repc.2017.11.013.De la Iglesia R., Loria-Kohen V., Zulet M. A., Martinez J. A., Reglero G., de Molina A. R. Dietary Strategies Implicated in the Prevention and Treatment of Metabolic Syndrome // Int J Mol Sci. 2016; 17 (11): 1877. DOI: 10.3390/ijms17111877.De la Iglesia R., Loria-Kohen V., Zulet M. A., Martinez J. A., Reglero G., de Molina A. R. Dietary Strategies Implicated in the Prevention and Treatment of Metabolic Syndrome // Int J Mol Sci. 2016; 17 (11): 1877. DOI: 10.3390/ijms17111877.Hu T., Mills K. T., Yao L., et al. Effects of Low-Carbohydrate Diets Versus Low-Fat Diets on Metabolic Risk Factors: A Meta-Analysis of Randomized Controlled Clinical Trials // American Journal of Epidemiology. 2017; 176 (7): 44-54. DOI: 10.1093/aje/kws264.Hu T., Mills K. T., Yao L., et al. Effects of Low-Carbohydrate Diets Versus Low-Fat Diets on Metabolic Risk Factors: A Meta-Analysis of Randomized Controlled Clinical Trials // American Journal of Epidemiology. 2017; 176 (7): 44-54. DOI: 10.1093/aje/kws264.Robberecht H., de Bruyne T., Hermans N. Effect of various diets on biomarkers of the metabolic syndrome // Int J Food Sci Nutr. 2016; 68 (5): 627-641. DOI: 10.1080/09637486.2016.1269726.Robberecht H., de Bruyne T., Hermans N. Effect of various diets on biomarkers of the metabolic syndrome // Int J Food Sci Nutr. 2016; 68 (5): 627-641. DOI: 10.1080/09637486.2016.1269726.Casas R., Sacanella E., Urpí-Sardà M., et al. The Effects of the Mediterranean Diet on Biomarkers of Vascular Wall Inflammation and Plaque Vulnerability in Subjects with High Risk for Cardiovascular Disease. A Randomized Trial // PLoS One. 2014; 9 (6): e100084. DOI: 10.1371/journal.pone.0100084.Casas R., Sacanella E., Urpí-Sardà M., et al. The Effects of the Mediterranean Diet on Biomarkers of Vascular Wall Inflammation and Plaque Vulnerability in Subjects with High Risk for Cardiovascular Disease. A Randomized Trial // PLoS One. 2014; 9 (6): e100084. DOI: 10.1371/journal.pone.0100084.Steckhan N., Hohmann C.-D., Kessler C., Dobos G., Michalsen A., Cramer H. Effects of different dietary approaches on inflammatory markers in patients with metabolic syndrome: A systematic review and meta-analysis // Nutrition. 2016; 32 (3): 338-348. DOI: 10.1016/j.nut.2015.09.010.Steckhan N., Hohmann C.-D., Kessler C., Dobos G., Michalsen A., Cramer H. Effects of different dietary approaches on inflammatory markers in patients with metabolic syndrome: A systematic review and meta-analysis // Nutrition. 2016; 32 (3): 338-348. DOI: 10.1016/j.nut.2015.09.010.Afifi L., Danesh M. J., Lee K. M., et al. Dietary Behaviors in Psoriasis: PatientReported Outcomes from a U.S. National Survey // Dermatol Ther (Heidelb). 2017; 7 (2): 227-242. DOI: 10.1007/s13555-017-0183-4.Afifi L., Danesh M. J., Lee K. M., et al. Dietary Behaviors in Psoriasis: PatientReported Outcomes from a U.S. National Survey // Dermatol Ther (Heidelb). 2017; 7 (2): 227-242. DOI: 10.1007/s13555-017-0183-4.Zuccotti E., Oliveri M., Girometta C., et al. Nutritional strategies for psoriasis: current scientific evidence in clinical trials // Eur Rev Med Pharmacol Sci. 2018; 22 (23): 8537-8551. DOI: 10.26355/eurrev_201812_16554.Zuccotti E., Oliveri M., Girometta C., et al. Nutritional strategies for psoriasis: current scientific evidence in clinical trials // Eur Rev Med Pharmacol Sci. 2018; 22 (23): 8537-8551. DOI: 10.26355/eurrev_201812_16554.Naldi L., Conti A., Cazzaniga S., et al. Diet and Physical Exercise in Psoriasis: A Randomized Controlled Trial // Br J Dermatol. 2014; 170 (3): 634-42. DOI: 10.1111/bjd.12735.Naldi L., Conti A., Cazzaniga S., et al. Diet and Physical Exercise in Psoriasis: A Randomized Controlled Trial // Br J Dermatol. 2014; 170 (3): 634-42. DOI: 10.1111/bjd.12735.Wilson P. B. Is Dietary Supplementation More Common Among Adults With Psoriasis? Results From the National Health and Nutrition Examination Survey // Complement Ther Med. 2014; 22 (1): 159-165. DOI: 10.1016/j.ctim.2013.12.007.Wilson P. B. Is Dietary Supplementation More Common Among Adults With Psoriasis? Results From the National Health and Nutrition Examination Survey // Complement Ther Med. 2014; 22 (1): 159-165. DOI: 10.1016/j.ctim.2013.12.007.Maleki M., Nahidi Y., Azizahari S., Meibodi N. T., Hadianfar A. Serum 25-OH Vitamin D Level in Psoriatic Patients and Comparison With Control Subjects // J Cutan Med Surg. 2016; 20 (3): 207-210. DOI: 10.1177/1203475415622207.Maleki M., Nahidi Y., Azizahari S., Meibodi N. T., Hadianfar A. Serum 25-OH Vitamin D Level in Psoriatic Patients and Comparison With Control Subjects // J Cutan Med Surg. 2016; 20 (3): 207-210. DOI: 10.1177/1203475415622207.Walsh J. S., Bowles S., Evans A. L. Vitamin D In Obesity // Curr Opin Endocrinol Diabetes Obes. 2017; 24 (6): 389-394. DOI:10.1097/MED.0000000000000371.Walsh J. S., Bowles S., Evans A. L. Vitamin D In Obesity // Curr Opin Endocrinol Diabetes Obes. 2017; 24 (6): 389-394. DOI:10.1097/MED.0000000000000371.Barrea L., Savanelli M. C., Di Somma C., et al. Vitamin D and its role in psoriasis: An overview of the dermatologist and nutritionist // Rev Endocr Metab Disord. 2017; 18 (2): 195-205. DOI: 10.1007/s11154-017-9411-6.Barrea L., Savanelli M. C., Di Somma C., et al. Vitamin D and its role in psoriasis: An overview of the dermatologist and nutritionist // Rev Endocr Metab Disord. 2017; 18 (2): 195-205. DOI: 10.1007/s11154-017-9411-6.Ju S. Y., Jeong H. S., Kim D. H. Blood vitamin D status and metabolic syndrome in the general adult population: a dose-response meta-analysis // J Clin Endocrinol Metabol. 2014; 99 (3): 1053-1063. DOI: 10.1210/jc.2013-3577.Ju S. Y., Jeong H. S., Kim D. H. Blood vitamin D status and metabolic syndrome in the general adult population: a dose-response meta-analysis // J Clin Endocrinol Metabol. 2014; 99 (3): 1053-1063. DOI: 10.1210/jc.2013-3577.Khan H., Kunutsor S. K., Franco Ò., Chowdhury R. Vitamin D, type 2 diabetes and other metabolic outcomes: a systematic review and meta-analysis of prospective studies // Proc Nutr Soc. 2013; 72 (1): 89-97. DOI: 10.1017/S0029665112002765.Khan H., Kunutsor S. K., Franco Ò., Chowdhury R. Vitamin D, type 2 diabetes and other metabolic outcomes: a systematic review and meta-analysis of prospective studies // Proc Nutr Soc. 2013; 72 (1): 89-97. DOI: 10.1017/S0029665112002765.Playford M. P., Dey A. K., Zierold C., et al. Serum active 1,25(OH)2D, but not inactive 25(OH)D vitamin D levels are associated with cardiometabolic and cardiovascular disease risk in psoriasis // Atherosclerosis. 2019; 289: 44-50. DOI: 10.1016/j.atherosclerosis.2019.08.006.Playford M. P., Dey A. K., Zierold C., et al. Serum active 1,25(OH)2D, but not inactive 25(OH)D vitamin D levels are associated with cardiometabolic and cardiovascular disease risk in psoriasis // Atherosclerosis. 2019; 289: 44-50. DOI: 10.1016/j.atherosclerosis.2019.08.006.Ford A. R., Siegel M., Bagel J., et al. Dietary Recommendations for Adults With Psoriasis or Psoriatic Arthritis From the Medical Board of the National Psoriasis Foundation: A Systematic Review // JAMA Dermatol. 2018; 154 (8): 934-950. DOI: 10.1001/jamadermatol.2018.1412.Ford A. R., Siegel M., Bagel J., et al. Dietary Recommendations for Adults With Psoriasis or Psoriatic Arthritis From the Medical Board of the National Psoriasis Foundation: A Systematic Review // JAMA Dermatol. 2018; 154 (8): 934-950. DOI: 10.1001/jamadermatol.2018.1412.Rosenbloom M., Gentili A. Vitamin Toxicity Clinical Presentation // Medscape. 2020. URL: https://emedicine.medscape.com/article/819426-clinical#showall (Accessed 11 Aug 2020). 22. Brooks M. Higher-Dose Vitamin D in Healthy Adults May Harm Bone Health // Medscape. 2019. URL: https://www.medscape.com/viewarticle/917334_print (Accessed 11 Aug 2020).Rosenbloom M., Gentili A. Vitamin Toxicity Clinical Presentation // Medscape. 2020. URL: https://emedicine.medscape.com/article/819426-clinical#showall (Accessed 11 Aug 2020). 22. Brooks M. Higher-Dose Vitamin D in Healthy Adults May Harm Bone Health // Medscape. 2019. URL: https://www.medscape.com/viewarticle/917334_print (Accessed 11 Aug 2020).Пигарова Е. А., Рожинская Л. Я., Белая Ж. Е. и др. Клинические рекомендации Российской ассоциации эндокринологов по диагностике, лечению и профилактике дефицита витамина D у взрослых // Проблемы эндокринологии. 2016; 63 (6): 392-426. DOI: 10.14341/probl2017636392-426.Pigarova E. A., Rozhinskaya L. Ya., Belaya Zh. E., et al. Klinicheskie rekomendatsii Rossiiskoi assotsiatsii endokrinologov po diagnostike, lecheniyu i profilaktike defitsita vitamina D u vzroslykh [Russian Association of Endocrinologists recommendations for diagnosis, treatment and prevention of vitamin D deficiency in adults] // Problemy endocrinologii. 2016; 63 (6): 392-426. DOI: 10.14341/probl2017636392-426.

The authors declare that there are no conflicts of interest present.